Login / Signup

Therapeutic N -heterocyclic carbenes: an interview with Alejandro Bugarin.

Alejandro Bugarin
Published in: Future medicinal chemistry (2022)
Dr Bugarin is currently an Associate Professor of Chemistry and Physics at Florida Gulf Coast University. He has published more than 50 peer-reviewed publications (h-index = 18). His research group is developing new methodology to improve or reveal novel reactivity of triazenes, N-Heterocyclic carbenes, heterobimetallic catalysts, and other versatile molecules. In addition, he recently joined research efforts to build on the isolation, characterization, and biological evaluation of natural products.
Keyphrases
  • highly efficient
  • genome wide
  • quality improvement
  • single cell
  • drug discovery
  • randomized controlled trial
  • transition metal
  • gene expression
  • systematic review